Current Liabilities
Other accrued liabilities
Boston Scientific Other accrued liabilities increased by 10.1% to $875M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.2%, from $923M to $875M. Over 5 years (FY 2020 to FY 2025), Other accrued liabilities shows a downward trend with a -3.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 1, 2026
How to read this metric
An unexpected increase may signal new operational commitments or changes in accounting for short-term obligations.
Detailed definition
This category captures miscellaneous short-term obligations that do not fall under standard accounts payable or accrued...
Peer comparison
Varies by company; peers in the medical device sector often have similar miscellaneous accruals related to regulatory or warranty obligations.
Metric ID:
current_liabilities_other_liabilities_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $680M | $669M | $783M | $1.03B | $784M | $752M | $761M | $787M | $940M | $882M | $814M | $827M | $770M | $891M | $887M | $923M | $952M | $862M | $795M | $875M |
| QoQ Change | — | -1.6% | +17.0% | +32.1% | -24.2% | -4.1% | +1.2% | +3.4% | +19.4% | -6.2% | -7.7% | +1.6% | -6.9% | +15.7% | -0.4% | +4.1% | +3.1% | -9.5% | -7.8% | +10.1% |
| YoY Change | — | — | — | — | +15.3% | +12.4% | -2.8% | -23.9% | +19.9% | +17.3% | +7.0% | +5.1% | -18.1% | +1.0% | +9.0% | +11.6% | +23.6% | -3.3% | -10.4% | -5.2% |
Range$669M – $1.03B
CAGR+5.5%
Avg YoY Growth+3.7%
Median YoY Growth+6.0%
Other accrued liabilities at Other Companies
Frequently Asked Questions
- What is Boston Scientific's other accrued liabilities?
- Boston Scientific (BSX) reported other accrued liabilities of $875M in Q1 2026.
- How has Boston Scientific's other accrued liabilities changed year-over-year?
- Boston Scientific's other accrued liabilities decreased by 5.2% year-over-year, from $923M to $875M.
- What is the long-term trend for Boston Scientific's other accrued liabilities?
- Over 5 years (2020 to 2025), Boston Scientific's other accrued liabilities has grown at a -3.7% compound annual growth rate (CAGR), from $958M to $795M.
- What does other accrued liabilities mean?
- Other miscellaneous short-term debts not classified elsewhere.